tuneTypical Dose
Use a gradual daily-fiber build rather than expecting an immediate laxative effect
Fiber Supplement
Acacia Fiber
Acacia senegal fiber
Evidence TierCWADA NOT PROHIBITED
watchEffect Window
Fiber-related bowel changes usually build over days to weeks.
check_circleCompliance
WADA NOT PROHIBITED
Overview
Clinical Summary
Acacia fiber is a gentle fermentable prebiotic fiber that may help bowel regularity, with the best constipation evidence still blend based and lower-confidence isolated gum-arabic evidence pointing to metabolic and GI support.
Acacia fiber is best understood as a mild, slowly fermented prebiotic fiber. It is often marketed for gut health and bowel regularity, and that framing is directionally reasonable. The strongest constipation signal still comes from blends that include acacia gum rather than isolated acacia-fiber monotherapy. At the same time, isolated gum-arabic trials now add some low-confidence support for GI and metabolic effects. That makes acacia fiber a plausible gentle-fiber option, but still not one of the most decisively validated constipation supplements.
Acacia fiber is a soluble fermentable fiber that can support stool bulk, microbial fermentation, and short-chain-fatty-acid production. The human evidence fits a gentle regularity and prebiotic role more than a strong laxative effect.
Outcomes
What This Is Expected To Influence
Primary Outcomes
- Possible improvement in bowel regularity and stool consistency
Secondary Outcomes
- Gentle prebiotic support
- Evidence is stronger for acacia-containing blends than isolated acacia fiber
Safety
Contraindications and Interactions
Contraindications
- Bowel obstruction or severe unexplained abdominal symptoms
Side effects
- Bloating
- Gas
Interactions
No entries provided
Avoid if
- You are using it instead of evaluating severe constipation or alarm symptoms
- You do not tolerate fermentable fibers well
Evidence
Study-level References
aca-SRC-001Randomized controlled trial
Sourceopen_in_newSo D, Whelan K, Rossi M, et al. Effects of a prebiotic formulation on the composition of the faecal microbiota of people with functional constipation. Br J Nutr. 2024;131(6):975-985. doi:10.1017/S0007114523002665. PMID:38165420.
Population: Adults with functional constipation.
Dose protocol: Acacia-gum-containing prebiotic blend for 21 days
Key findings: Increased complete spontaneous bowel motions and improved stool consistency.
Notes: Best recent adult evidence, but blend specific.
Paper content
This is the best recent human anchor that includes acacia gum, but it is a blend study rather than isolated acacia fiber. It supports the idea that acacia-containing prebiotic formulas can help constipation and stool consistency, but it should not be overread as proof that acacia fiber alone is a strong constipation treatment.
aca-SRC-002Randomized controlled trial
Sourceopen_in_newLoening-Baucke V, Krishna R, Pashankar DS. A randomized, prospective, comparison study of a mixture of acacia fiber, psyllium fiber, and fructose vs polyethylene glycol 3350 with electrolytes for the treatment of chronic functional constipation in childhood. Eur J Pediatr. 2012;171(9):1277-1283. doi:10.1007/s00431-012-1760-5. PMID:22677568.
Population: Children with chronic functional constipation.
Dose protocol: Mixed acacia-psyllium-fructose product over 8 weeks
Key findings: Similar constipation improvement to PEG 3350 with electrolytes in children.
Notes: Supportive mixed-fiber evidence only.
Paper content
This pediatric trial is relevant because it shows that an acacia-containing mixed-fiber product can work about as well as PEG in chronic constipation. But it still does not isolate acacia fiber, so it should be treated as supportive blend evidence rather than direct proof for acacia alone.
aca-SRC-003Randomized, double-blinded, placebo-controlled trial.
Sourceopen_in_newBabiker R, Elmusharaf K, Keogh MB, Saeed AM. Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial. Lipids Health Dis. 2018;17(1):56. doi:10.1186/s12944-018-0711-y. PMID:29558953.
Population: Adults with type 2 diabetes mellitus.
Dose protocol: 30 g/day gum arabic (Acacia senegal) versus 1 g pectin placebo for 3 months
Key findings: Significant reductions in BMI (2%), visceral adiposity index (23.7%), and systolic blood pressure (7.6%) in the gum arabic group.
Notes: Isolated gum arabic RCT in type 2 diabetes patients. Predominantly female sample limits generalizability.
Paper content
This double-blind RCT in 91 adults with type 2 diabetes tested 30 g/day gum arabic versus pectin placebo for 3 months. The gum arabic group showed significant reductions in BMI (2%), visceral adiposity index (23.7%), and systolic blood pressure (7.6%). The study supports gum arabic as a safe adjunct that may help prevent weight gain and modulate adipose tissue dysfunction in diabetic patients. The predominantly female sample and single-region recruitment limit generalizability.
aca-SRC-004Single-blind, randomized, placebo-controlled trial.
Sourceopen_in_newJarrar AH, Stojanovska L, Apostolopoulos V, Feehan J, Bataineh MF, Cheikh Ismail L, Al Dhaheri AS. The Effect of Gum Arabic (Acacia Senegal) on Cardiovascular Risk Factors and Gastrointestinal Symptoms in Adults at Risk of Metabolic Syndrome: A Randomized Clinical Trial. Nutrients. 2021;13(1):194. doi:10.3390/nu13010194. PMID:33435475.
Population: Adults at risk of or with metabolic syndrome.
Dose protocol: 20 g/day gum arabic versus 1 g pectin for 12 weeks
Key findings: Significant decreases in blood pressure, fasting plasma glucose, and fat-free body mass. Improved self-reported bloating and bowel movements.
Notes: Metabolic syndrome risk population. Supports cardiovascular and GI benefits of isolated gum arabic.
Paper content
This 12-week single-blind RCT randomized 80 adults at risk of metabolic syndrome to 20 g/day gum arabic or pectin placebo. Sixty-one participants completed the trial. The gum arabic group showed significant reductions in systolic and diastolic blood pressure, fasting plasma glucose, and fat-free body mass. Self-reported bloating and bowel movements also improved, and appetite scores decreased. The study supports gum arabic as a safe and potentially beneficial dietary adjunct for cardiovascular and metabolic risk factors.
aca-SRC-005Systematic review.
Sourceopen_in_newAl-Jubori Y, Babiker Ahmed NT, Albusaidi R, Madden J, Das S, Sirasanagandla SR. The Efficacy of Gum Arabic in Managing Diseases: A Systematic Review of Evidence-Based Clinical Trials. Biomolecules. 2023;13(1):138. doi:10.3390/biom13010138. PMID:36671523.
Population: Human participants across 29 clinical trials spanning multiple disease conditions.
Dose protocol: Systematic review of 29 clinical trials of gum arabic across multiple conditions
Key findings: Gum arabic altered lipid profiles, renal function, blood pressure, inflammatory markers, and adiposity. Demonstrated anti-inflammatory, prebiotic, and antibacterial properties across multiple disease states.
Notes: Broadest systematic review of gum arabic clinical evidence to date. Individual study quality varies.
Paper content
This systematic review synthesized 29 clinical trials examining gum arabic across multiple disease states. The review found evidence that gum arabic favorably altered lipid profiles, renal function markers, blood pressure, inflammatory markers, and adiposity. It demonstrated anti-inflammatory, prebiotic, and antibacterial properties across conditions including sickle cell anemia, metabolic disorders, periodontal disease, and renal disease. This is the most comprehensive systematic review of gum arabic clinical evidence to date, supporting its broad therapeutic potential as a dietary adjunct.